Inflammatory Biomarkers in Ocular Surface in Patients With Primary Open Angle Glaucoma and Ocular Hypertension Under Topical Prostaglandin Therapy
Latest Information Update: 05 Nov 2024
At a glance
- Drugs Latanoprost (Primary) ; Latanoprost (Primary) ; Tafluprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Biomarker; Pharmacodynamics
Most Recent Events
- 31 Oct 2024 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 31 Oct 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2025.
- 01 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.